Literature DB >> 19701716

Elevated serum xanthine oxidase activities in patients with Henoch-Schonlein purpura.

Tao Chen, Zai-Pei Guo, Yu-hong Zhang, Ying Gao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19701716     DOI： 10.1007/s10067-009-1253-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  Increased xanthine oxidase in the thalamus and putamen in depression.

Authors:  Tanja Maria Michel; Sybille Camara; Thomas Tatschner; Sophia Frangou; Abigail Jane Sheldrick; Peter Riederer; Edna Grünblatt
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

2.  Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

Authors:  R Butler; A D Morris; J J Belch; A Hill; A D Struthers
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

Review 3.  The molecular sources of reactive oxygen species in hypertension.

Authors:  Paolo Puddu; Giovanni Maria Puddu; Eleonora Cravero; Marzia Rosati; Antonio Muscari
Journal:  Blood Press       Date:  2008       Impact factor: 2.835

4.  Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Halil Kocamaz; Aşkin Hekimoğlu; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980
  4 in total
  2 in total

1.  Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.

Authors:  T Chen; Z-P Guo; M-M Li; J-Y Li; X-Y Jiao; Y-H Zhang; H-J Liu
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

2.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.